跳至主要内容
临床试验/NCT05820685
NCT05820685终止4 期

Dronabinol On the Pain Experience (DOPE): a Pragmatic Randomized Clinical Trial

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 484 人开始时间: 2023年7月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
484
试验地点
1
主要终点
Total Morphine Milligram Equivalents (MME) Per Day

研究概览

简要总结

The purpose of this study is to identify the effect dronabinol has on opioid exposure when used as an adjunct to the current standard multi-modal pain regimen (MMPR)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients admitted to the floor, Surgical Intermediate Medical Unit (SIMU), Shock-Trauma ICU (STICU) at Memorial Herman Hospital-Texas Medical Center(MHH-TMC)

排除标准

  • Patients placed in observation unit
  • Non-acute trauma
  • Admitted with primary burn injury
  • Expired prior to admission
  • Discharge from emergency department
  • Left against medical advice

研究组 & 干预措施

Standard of Care

Active Comparator

干预措施: Standard of Care (acetaminophen +naproxen +gabapentin + as needed oxycodone or Tramadol) (Drug)

Standard of Care + Dronabinol

Experimental

干预措施: Standard of Care (acetaminophen +naproxen +gabapentin + as needed oxycodone or Tramadol) (Drug)

Standard of Care + Dronabinol

Experimental

干预措施: Dronabinol (Drug)

结局指标

主要结局

Total Morphine Milligram Equivalents (MME) Per Day

时间窗: From time of admission to time of discharge (about 11 days after admission)

This will be calculated by calculated by taking the total of MMEs from all opioids received and dividing by length of stay

次要结局

  • Total Morphine Milligram Equivalents (MME) Over Hospital Stay(From time of admission to time of discharge (about 11 days after admission))
  • Number of Participants Discharged Form Hospital Without a Prescription for an Opioid Medication(Discharge (about 11 days after admission))
  • Pain as Assessed by the Defense and Veterans Pain Rating Scale (DVPRS)(From time of admission to time of discharge (about 11 days after admission))
  • Number of Participants Discharged Form Hospital With a Prescription for an Opioid Medication(Discharge (about 11 days after admission))
  • Number of Hospital Free Days(30 days)
  • Number of Participants That Have Incidences of Opioid-related Complications, Such as Ileus, Aspiration, Unplanned Intubation, Unplanned Admission to an Intensive Care Unit, and Use of an Opioid-reversal Agent.(From time of admission to time of discharge (about 11 days after admission))
  • Hospital Length of Stay(From time of admission to time of discharge (about 11 days after admission))
  • ICU Length of Stay (Participants With >0 ICU Days)(From time of admission to ICU to time of discharge from ICU (about 12 days after admission))
  • Number of Days on a Ventilator (Participants With > 0 Days on a Ventilator)(From time of intubation to time of extubation (about 14 days after admission))
  • Number of ICU Free Days (Participants With >0 ICU Days)(30 days)
  • Number of Ventilator Free Days (Participants With >0 Days on a Ventilator)(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

John Andrew Harvin

Associate Professor

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验